|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01681 CONSUN PHARMA
Nominal 
17.390 +0.890 (+5.394%) Non-current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Investment Properties | 13,648 | -3.486% | 14,141 | 14,634 | 15,127 | 15,620 |
| Property, plant, equip. & others | 804,190 | 0.829% | 797,581 | 739,056 | 746,213 | 724,633 |
| Land & other Lease Assets | 116,984 | -8.577% | 127,959 | 124,652 | 128,786 | 133,815 |
| Intangible Assets | 265,608 | -1.246% | 268,960 | 283,140 | 311,904 | 341,664 |
| Interests in Asso. & JCEs | 33,337 | 235.585% | 9,934 | 0 | 0 | 0 |
| Other Non-current Assets | 571,498 | 586.946% | 83,194 | 68,432 | 67,679 | 91,177 |
| 1,805,265 | 38.678% | 1,301,769 | 1,229,914 | 1,269,709 | 1,306,909 | |
Current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Inventories | 271,405 | -6.308% | 289,677 | 367,087 | 276,080 | 243,035 | |
| Trade Receivables | 307,718 | 3.409% | 297,573 | 255,838 | 259,562 | 351,226 | |
| Cash & Bank Balances | 1,234,384 | -57.547% | 2,907,682 | 2,748,262 | 2,450,173 | 2,196,323 | |
| Other Current Assets | 2,791,251 | 164.228% | 1,056,381 | 906,893 | 636,856 | 265,245 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 4,604,758 | 1.174% | 4,551,313 | 4,278,080 | 3,622,671 | 3,055,829 | ||
Current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||
| Trade Payables | 130,503 | 72.525% | 75,643 | 83,098 | 59,891 | 66,638 | ||
| S-T Debt & Leases | 209,709 | -19.269% | 259,763 | 507,636 | 454,229 | 602,426 | ||
| Other Current Liabilities | 1,090,105 | 5.284% | 1,035,394 | 904,262 | 836,368 | 688,343 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 1,430,317 | 4.342% | 1,370,800 | 1,494,996 | 1,350,488 | 1,357,407 | |||
| Net Current Assets | 3,174,441 | -0.191% | 3,180,513 | 2,783,084 | 2,272,183 | 1,698,422 | ||
| Total Assets Less Current Liabilities | 4,979,706 | 11.098% | 4,482,282 | 4,012,998 | 3,541,892 | 3,005,331 | ||
Non-current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||||
| L-T Debt & Leases | 3,211 | -56.643% | 7,406 | 3,898 | 5,947 | 8,547 | |||
| Other Non-current Liabilities | 138,625 | 69.419% | 81,824 | 90,388 | 96,940 | 86,003 | |||
| 141,836 | 58.956% | 89,230 | 94,286 | 102,887 | 94,550 | ||||
Capital and Reserves
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||||
| Share Capital | 67,226 | -0.122% | 67,308 | 63,812 | 63,450 | 64,800 | ||||
| Reserves | 4,467,807 | 10.856% | 4,030,295 | 3,562,691 | 3,081,689 | 2,552,905 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 4,535,033 | 10.675% | 4,097,603 | 3,626,503 | 3,145,139 | 2,617,705 | ||||
| Non-controlling Interests | 302,837 | 2.501% | 295,449 | 292,209 | 293,866 | 293,076 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 4,837,870 | 10.125% | 4,393,052 | 3,918,712 | 3,439,005 | 2,910,781 | |||||
Commitments and Contingent Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Commitments | -- | -- | 493,985 | 532,903 | 450,758 | 482,495 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 27/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,078,067 |
| %Change | 18.409% |
| EPS / (LPS) | RMB 1.270 |
| NBV Per Share (¥) | RMB 5.345 |